2:20cv2706 • June 18, 2020
Class Period Start
March 11, 2020
Class Period End
September 14, 2020
PSLRA Deadline
August 17, 2020
Case Allegations
10b5 + Sec11
10b-5 Statutes of Repose
Mar 11, 2023
Sec11 Statutes of Repose
May 7, 2023
Country
United States
Court
Federal Court
Please note that for cases in the settlement stage, claims are handled by the claims administrator and NOT Levi & Korsinsky. Any information or documentation previously provided to us does not constitute submission of a claim. If you need to file a claim, check the status of a claim, or have questions regarding distribution of settlement funds, please contact the claims administrator below.
Claim Deadline
June 23, 2023
Settlement Fund
$8,100,000
Settlement Status
Final Approval
Settlement Class
All persons or entities that purchased Chembio common stock directly in and/or traceable to Chembio’s public offering of common stock pursuant to a Prospectus supplement dated May 7, 2020 (the “May 2020 Offering”) or if you purchased or otherwise acquired Chembio common stock during the period between March 12, 2020 through June 16, 2020, inclusive.
Claim Administrator
Gilardi & Co. LLC
Chembio Securities Settlement
Claims Administrator
c/o Gilardi & Co. LLC
P.O. Box 301134
Los Angeles, CA 90030-1134
+1 866-796-2048
[email protected]
Settlement Website
http://www.chembiosecuritiessettlement.com/Hearing Date
June 5, 2023
Opt-out Deadline
May 15, 2023
Settlement Note
Download hereProof Of Claim
Download hereJun 6, 2023
The court has granted final approval of the settlement. Eligible investors who submit valid claims may receive a payment once the claims review and distribution process is completed.
Feb 3, 2023
Preliminary Approval of Settlement
The court has granted preliminary approval of a proposed settlement. This means the settlement can move forward for further consideration, but it has not yet received final approval. Potential class members will generally receive notice explaining the settlement, their rights, and any deadlines for submitting a claim, objecting to the settlement, or choosing not to participate.
Feb 3, 2023
To receive your portion of the recovery (if you are eligible), you must submit this form to the claims administrator by the deadline indicated on the form itself. If you do not submit this form in time, you will not be entitled to compensation. If you have questions about how to complete the form, you should contact the claims administrator.
Jul 26, 2022
A new complaint has been filed on behalf of certain investors in CHEMBIO DIAGNOSTICS, INC.. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.
Feb 23, 2022
Motion to Dismiss Denied in Part
The court has determined that plaintiffs have adequately alleged some of their claims, but have failed to adequately allege other claims. The judge has therefore denied in part the motion to dismiss filed by defendants and written an order stating which claims are dismissed and which remain. The case will proceed and parties will litigate the remaining claims.
Mar 26, 2021
After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.
Feb 12, 2021
A new complaint has been filed on behalf of certain investors in CHEMBIO DIAGNOSTICS, INC.. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.
Dec 29, 2020
The court has appointed a lead plaintiff to represent the interests of investors in the lawsuit. The lead plaintiff works with the attorneys handling the case, helps oversee the litigation, and represents the interests of the proposed class.
Aug 17, 2020
Another plaintiff has filed a complaint on behalf of investors in CHEMBIO DIAGNOSTICS, INC.. The allegations and class definitions are substantively the same.
Jul 3, 2020
Another plaintiff has filed a complaint on behalf of investors in CHEMBIO DIAGNOSTICS, INC.. The allegations and class definitions are substantively the same.
TOP